The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Non‐alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis
Open accessAbstract
Non‐alcoholic fatty liver disease (NAFLD) is the most common liver disease in developed countries, and accumulating evidence suggests it as the hepatic manifestation of the metabolic syndrome (MS). Although the published prevalence of hepatocellular carcinoma (HCC) is low in NAFLD/NASH patients, most of these data have been derived from areas endemic for viral hepatitis. We recruited 162 adults with HCC between February 2007 and March 2008, investigated the underlying etiologies and determined the prevalence of the MS and related features within each group. Patients with NAFLD/NASH‐associated HCC exhibited a higher prevalence of metabolic features (Type 2 diabetes mellitus, hypertension, dyslipidemia, coronary artery disease) compared to non‐NAFLD/NASH‐HCC. Intriguingly, a significant number (41.7%; p < 0.005) of individuals with NAFLD/NASH‐HCC had no evidence of cirrhosis. Patients with alcohol‐induced liver disease also displayed many features (14/19, 73.7%) of the MS, although, in contrast to NAFLD/NASH‐HCC, alcohol‐associated HCC was highly associated with cirrhosis (95.0%; p = 0.064). NAFLD/NASH as the hepatic entity of the MS may itself pose a risk factor for HCC, even in the absence of cirrhosis. The MS may also promote development of HCC among those with alcoholic liver disease. Increased awareness of liver manifestations in the MS may instigate early interventions against developing HCC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Nonalcoholic Steatohepatitis: A Proposal for Grading and Staging The Histological Lesions
Brunt, E. M., Janney, C. G., Di Bisceglie, A. M., Neuschwander-Tetri, B. A., & Bacon, B. R. (1999) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.1999.01377.x · Cited by 3,907
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
Calle, E. E., & Kaaks, R. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1408 · Cited by 3,613
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications
Fabbrini, E., Sullivan, S., & Klein, S. (2010) · Hepatology · doi:10.1002/hep.23280 · Cited by 2,100
Park, E. J., Lee, J. H., Yu, G.-Y., He, G., Ali, S. R., Holzer, R. G., Österreicher, C. H., Takahashi, H., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2009.12.052 · Cited by 1,764
Nonalcoholic fatty liver disease
Adams, L. A. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.045232 · Cited by 1,610
Sattar, N., Gaw, A., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Haffner, S. M., Isles, C., Macfarlane, P. W., Packard, C. J., Cobbe, S. M., et al. (2003) · Circulation · doi:10.1161/01.cir.0000080897.52664.94 · Cited by 1,506
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,336
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Bedogni, G., Miglioli, L., Masutti, F., Tiribelli, C., Marchesini, G., & Bellentani, S. (2005) · Hepatology · doi:10.1002/hep.20734 · Cited by 1,263
Current Strategy for Staging and Treatment: The BCLC Update and Future Prospects
Forner, A., Reig, M. E., Rodriguez de Lope, C., & Bruix, J. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1247133 · Cited by 1,110
Epidemiology of Non-Alcoholic Fatty Liver Disease
Bellentani, S., Scaglioni, F., Marino, M., & Bedogni, G. (2010) · Digestive Diseases · doi:10.1159/000282080 · Cited by 1,026
Hepatocellular carcinoma: Recent trends in the United States
El-Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 972
Alcohol and hepatocellular carcinoma
Morgan, T. R., Mandayam, S., & Jamal, M. M. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.020 · Cited by 625
Deletion of NEMO/IKKγ in Liver Parenchymal Cells Causes Steatohepatitis and Hepatocellular Carcinoma
Luedde, T., Beraza, N., Kotsikoris, V., van Loo, G., Nenci, A., De Vos, R., Roskams, T., Trautwein, C., & Pasparakis, M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.12.016 · Cited by 597
Paradis, V., Zalinski, S., Chelbi, E., Guedj, N., Degos, F., Vilgrain, V., Bedossa, P., & Belghiti, J. (2009) · Hepatology · doi:10.1002/hep.22734 · Cited by 571
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Zoppini, G., Zenari, L., Cigolini, M., Falezza, G., & Arcaro, G. (2006) · Diabetes Care · doi:10.2337/dc06-0135 · Cited by 401
Metabolic syndrome and hepatocellular carcinoma: Two growing epidemics with a potential link
Siegel, A. B., & Zhu, A. X. (2009) · Cancer · doi:10.1002/cncr.24687 · Cited by 399
Hepatocellular carcinoma: A worldwide problem and the major risk factors
Simonetti, R. G., Camm�, C., Fiorello, F., Politi, F., D'Amico, G., & Pagliaro, L. (1991) · Digestive Diseases and Sciences · doi:10.1007/bf01297149 · Cited by 387
JNK1 but not JNK2 promotes the development of steatohepatitis in mice
Schattenberg, J. M., Singh, R., Wang, Y., Lefkowitch, J. H., Rigoli, R. M., Scherer, P. E., & Czaja, M. J. (2006) · Hepatology · doi:10.1002/hep.20999 · Cited by 384
Yatsuji, S., Hashimoto, E., Tobari, M., Taniai, M., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05640.x · Cited by 318
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2262-x · Cited by 308
Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus.
Prashanth, M., Ganesh, H. K., Vima, M. V., John, M., Bandgar, T., Joshi, S., Shah, S., Rathi, P. M., Joshi, A. S., Thakkar, H. U., et al. (2009) · PubMed · Cited by 217
TAK1 Suppresses a NEMO-Dependent but NF-κB-Independent Pathway to Liver Cancer
Bettermann, K., Vucur, M., Haybaeck, J., Koppe, C., Janssen, J., Heymann, F., Weber, A., Weiskirchen, R., Liedtke, C., Gassler, N., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.03.021 · Cited by 217
Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis
Kawada, N., Imanaka, K., Kawaguchi, T., Tamai, C., Ishihara, R., Matsunaga, T., Gotoh, K., Yamada, T., & Tomita, Y. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0112-0 · Cited by 204
JNK1-dependent PUMA Expression Contributes to Hepatocyte Lipoapoptosis
Cazanave, S. C., Mott, J. L., Elmi, N. A., Bronk, S. F., Werneburg, N. W., Akazawa, Y., Kahraman, A., Garrison, S. P., Zambetti, G. P., Charlton, M. R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.022491 · Cited by 191
Anzola, M. (2004) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2004.00521.x · Cited by 191
Moderate Alcohol Consumption Reduces Risk of Ischemic Stroke: The Northern Manhattan Study
Elkind, M. S. V., Sciacca, R., Boden-Albala, B., Rundek, T., Paik, M. C., & Sacco, R. L. (2006) · Stroke · doi:10.1161/01.str.0000195048.86810.5b · Cited by 185
Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data
Negro, F., & Sanyal, A. J. (2009) · Liver International · doi:10.1111/j.1478-3231.2008.01950.x · Cited by 169
NASH and cryptogenic cirrhosis: A histological analysis
Caldwell, S. H., Lee, V. D., Kleiner, D. E., Al‐Osaimi, A. M. S., Argo, C. K., Northup, P. G., & Berg, C. L. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31748-x · Cited by 140
Trends in the incidence of cancer in Qidong, China, 1978–2002
Chen, J., Zhu, J., Parkin, D. M., Zhang, Y., Lu, J., Zhu, Y., & Chen, T. (2006) · International Journal of Cancer · doi:10.1002/ijc.21952 · Cited by 118
Mortality in relation to alcohol consumption: a prospective study among male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh369 · Cited by 117
Arun, J. S., Jhala, N., Lazenby, A. J., Clements, R. H., & Abrams, G. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9041-2 · Cited by 87
Herzer, K., Hofmann, T. G., Teufel, A., Schimanski, C. C., Moehler, M. H., Kanzler, S., Schulze‐Bergkamen, H., & Galle, P. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2831 · Cited by 87
Self-citationFleig, S. V., Choi, S. S., Yang, L., Jung, Y., Omenetti, A., VanDongen, H. M. A., Huang, J., Sicklick, J. K., & Diehl, A. M. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700689 · Cited by 86
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis
Téllez-Ávila, F. I., Sánchez-Ávila, J. F., García-Saenz-de-Sicilia, M., Chávez-Tapia, N. C., Franco-Guzmán, A. M., López-Arce, G., Cerda-Contreras, E., & Uribe, M. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.4771 · Cited by 69
Wedemeyer, I., Bechmann, L. P., Odenthal, M., Jochum, C., Marquitan, G., Drebber, U., Gerken, G., Gieseler, R. K. H., Dienes, H. P., & Canbay, A. E. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.023 · Cited by 66
Self-citationEvolution of systemic therapy of advanced hepatocellular carcinoma
Yau, T. C. C., Chan, P., Epstein, R. J., & Poon, R. T. P. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.6437 · Cited by 66
Chagas, A. L., Kikuchi, L., de Oliveira, C. P. M. S., Paranaguá‐Vezozzo, D. C., de Mello, E. S., de Oliveira, A. C. S., Cella, L. C., Herman, P., Bacchella, T., Caldwell, S. H., et al. (2009) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2009005000019 · Cited by 64
Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells
Bechmann, L. P., Zahn, D., Gieseler, R. K. H., Fingas, C. D., Marquitan, G., Jochum, C., Gerken, G., Friedman, S. L., & Canbay, A. E. (2009) · Hepatology Research · doi:10.1111/j.1872-034x.2008.00485.x · Cited by 42
Self-citationNonalcoholic fatty liver disease
Madan, P. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1050094 · Cited by 31
Ghosh, A., Liu, T., Khoury, M. J., & Valdez, R. A. (2009) · Public Health Genomics · doi:10.1159/000262330 · Cited by 23
Metwally, M. A., Zein, C. O., & Zein, N. N. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9366-z · Cited by 16
Cited by
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Byrne, C. D., & Targher, G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.12.012 · Cited by 3,042
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace
Baffy, G., Brunt, E. M., & Caldwell, S. H. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.027 · Cited by 858
Metadata
- Authors
- Ertle, J., Dechêne, A., Sowa, J., Penndorf, V., Herzer, K., Kaiser, G., Schlaak, J. F., Gerken, G., Syn, W., & Canbay, A.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2011-03-14
- Volume
- 128
- Issue
- 10
- Pages
- 2436-2443
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2002034811
- Cited by
- 518
- References
- 46
- FWCI
- 18.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.